Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia
作者： Daniel J DeAngelo , Brian A Jonas , Jane L Liesveld , Dale L Bixby , Anjali S Advani
DOI:
关键词:
摘要: … chemotherapy in the same R/R AML population, as well as in combination with a standard (7 + 3) frontline AML … of older patients newly diagnosed with AML. The initial dose-escalation …
ashpublications.org参考文章(0)